Abstract
Introduction
Atherosclerosis is now well recognized as a chronic inflammatory disorder involving many immune cell types [1] . In the 1960s macrophages were the first inflammatory cells to be identified within atherosclerotic plaques [2] .
Macrophages are a key feature of all stages of atherogenesis where they have a very significant impact on lesion progression. As part of their innate immune role, macrophages infiltrate developing lesions and respond to and phagocytose oxidized low-density lipoprotein (oxLDL). This results in the secretion of cytokines, chemokines and toxic oxygen and nitrogen radicals that not only direct and amplify the local immune response but also leads to tissue injury. Moreover macrophages cause plaque destabilization, rupture and thrombosis,
highlighting their destructive role [3] . However, macrophages are heterogeneous cells and can also develop functions that facilitate tissue repair, remodelling and restoration of normal tissue homeostasis [4, 5] 
Current concepts in monocyte heterogeneity
An early event in atherosclerosis is monocyte recruitment to the activated endothelium and subsequent diapedesis in response to chemoattractive stimuli. These events have been extensively reviewed elsewhere [6] [7] [8] [12] [13] [14] . These cells are larger (18.4 m) [15] and phagocytic, and demonstrate low proinflammatory cytokine production and high interleukin (IL)-10 when activated in vitro with lipopolysaccharide (LPS). A recent genomic study concluded that that in patients with coronary heart disease these monocytes express a more anti-inflammatory profile [16] [50] and kidney [51, 52] [63] .
Macrophage heterogeneity and in vitro classification
Macrophage heterogeneity exists in tissue in vivo although the phenotype observed may not directly correspond to simplistic phenotypes generated in vitro. In vivo, macrophages are exposed to a complex microenvironment generated from several cell types. Fig. 1 ). [65] . Moreover, under appropriate conditions, infiltrating monocytes differentiate into osteoclast-like cells within plaques and promote lesion calcification [9] , whereas macrophages exposed to particulate calcium mineral have been reported to undergo osteoclastic differentiation [66] . [76] and human beings [77] . [78] . On the other hand, weight reduction promotes the occurrence of M2-like macrophages in adipose tissue of obese patients [79, 80] . [81, 82] . Agonizing PPAR-␥ could therefore promote M2 polarization in adipose tissue protecting from insulin resistance [83] . Together, these studies suggest, as is the case for atherosclerosis, M1 macrophages are pathogenic and polarization of macrophages towards an M2-status has potential as a new strategy for treatment of obesity-induced metabolic disorders. [84, 85] [70] . Conversely, in mice, selective inactivation of macrophage PPAR-␥ impairs M2 activation and exacerbated diet-induced obesity [82] , suggesting that PPAR-␥ agonists have therapeutic potential. However PPAR-␥ activation did not switch the function of M1 macrophages to M2 in atherosclerotic lesions [70] . PPAR-␥ activation by TZD also increased transcription of many genes that cause weight gain and increased LDL cholesterol [92] [93] . In experimental models macrophage-specific loss of LXRs resulted in a marked increase in lesion size [94] while LXR agonists reduced the size of preexisting plaques and this reduction was dependent on macrophage LXR activity [95] [96] .
The way infiltrating macrophages are activated is dictated by a multitude of signals impinging on their receptors (see

These signals change during the evolution of the underlying disease process and have the capacity to influence the outcome of the disease. Other less-defined macrophage subtypes induced by metabolic factors are liable to be present in atherosclerotic plaques. For example, uptake of oxidized or acetylated LDL, as a model of foam cell formation increases the expression of commonly used M1 markers and transcription factors such as iNOS, metalloproteinase-1 and NF-B [64]. Fatty acids present in developing plaques activate an inflammatory programme; saturated fatty acids are robustly pro-inflammatory, polyunstaturated fatty acids are weakly inflammatory or neutral while omega-3 unsaturated fatty acids induce more anti-inflammatory functions
Macrophage heterogeneity within atherosclerotic plaques
Importantly, Lumberg et al. reported that high fat diet-induced obesity caused a switch in adipose tissue macrophages from an M2 anti-inflammatory state to M1 proinflammatory cells [76] favouring inflammation. Further studies by Fujisaka et al. confirmed that insulin resistance is associated with both increased numbers of M1 macrophages and an increased M1/M2 ratio in adipose tissue
The nuclear receptor PPAR-␥ is required for maturation of M2 macrophages and deletion of the PPAR-␥ gene in myeloid cells results in a shift of macrophage differentiation towards M1, predisposing mice to diet-induced obesity, insulin resistance and glucose intolerance
Macrophage modulation by pathogens and tumours
Several pathogens have developed systems to dampen the innate response and survive the hostile environment produced by M1 macrophages. This is achieved by inhibiting pro-inflammatory intracellular pathways and/or enhancing anti-inflammatory responses (M1-to M2-macrophage switch). Moreover, to avoid macrophage-mediated destruction, pathogens can interfere with receptor-mediated recognition, phagocytosis and trafficking of bacteria to degradative lysosomes (reviewed in
Statins are effective cholesterol-lowering agents that also dampen immune responses through inhibition of macrophage inflammatory activity [97] , again possibly via PPARs [98] . In one study, statin treatment slightly increased the number of plaque macrophages yet other markers of inflammation were reduced with the authors concluding that it is not the presence of macrophages but activation and subsequent protease and cytokine release that is attenuated by statin use [98] 
Macrophages as a target to non-invasively image vulnerable plaques
The abundance of macrophages in unstable plaques makes their visualization very relevant for both diagnostic purposes and for the evaluation of therapeutic interventions [103] [106] . Inflammatory cytokines within the inflamed lesion enhance phagocytic uptake of USPIOs [107] and after uptake there is the added advantage in that production of TNF-␣ is decreased and anti-inflammatory IL-10 is enhanced. [108] . New MRI probes for imaging plaque macrophages include macrophage scavenger receptor-targeted immunomicelles loaded with gadolinium [109] . Iodine-containing contrast agents have also labelled lesional macrophages for detection with computed tomography [110] .
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